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In traditional Chinese medicine (TCM), purgation is indicated when a person suﬀers an illness due to the accumulation of evil
internal heat. Obese individuals with a large belly, red face, thick and yellow tongue fur, constipation, and avoidance of heat are
thought accumulates of evil internal heat, and they are also treated with purgatives such as Ta-Cheng-Chi-Tang (TCCT), Xiao-
Chen-Chi-Tang (XCCT), and Tiao-Wei-Chen-Chi-Tang (TWCCT) by TCM doctors. In previous studies, our group found that
TCCT has potent anti-inﬂammatory activity, and that XCCT is an eﬀective antioxidant. Since rhubarb is the principle herb in
these three prescriptions, we will ﬁrst present a thorough review of the literature on the demonstrated eﬀect (or lack of eﬀect)
of rhubarb and rhubarb-containing polyherbal preparations on lipid and weight control. We will then continue our research
with an investigation of the anti-obesity and lipid-lowering eﬀect of TCCT, XCCT, TWCCT, and rhubarb extracts using two
animal models. TWCCT lowered the serum triglyceride concentration as much as fenoﬁbrate in Triton WR-1339-treated mice.
Daily supplementation with XCCT and TWCCT signiﬁcantly attenuated the high-fat-diet-induced hypercholesterolemia in rats.
In addition, TWCCT also signiﬁcantly lowered the high-fat-diet-induced hypertriglycemia. Although feeding high-fat diet rats
with these extracts did not cause loose stools or diarrhea or other deleterious eﬀects on renal or hepatic function. None of these
extracts lowered the body weight of rats fed on high-fat diet. In conclusion, the results suggest that XCCT and TWCCT might exert
beneﬁcial eﬀects in the treatment of hyperlipidemia.
1.Introduction
In traditional Chinese medicine (TCM), obesity is classiﬁed
into diﬀerent types based on etiology; for example, stagna-
tion of qi, blood, or phlegm; or a deﬁciency in the spleen or
kidney energy. Obese individuals with a large belly, red face,
thick and yellow tongue fur, constipation, and avoidance
of heat are thought to have accumulated evil heat in the
stomach. TCM doctors typically have used purgation to
clear the evil heat in such individuals [1]. Ta-Cheng-Chi-
Tang (TCCT), Xiao-Chen-Chi-Tang (XCCT), and Tiao-Wei-
Chen-Chi-Tang (TWCCT) are the three famous purgative
decoctions originally mentioned in Shan han lun,o n eo f
the most important Chinese medical books, written by
Chang Chung-Ching (∼200 AD). These three purgatives are
indicated when there is a need to purge internal evil heat that
has raised symptoms like abdominal pain and distention,
thirst, and fever [2]. Purgatives are also used to treat a type of
obese person who has excessive evil internal heat. However,
scientiﬁc research on the eﬃcacies and mechanisms of these
purgatives as anti-obesity agents is still very limited.
Rhubarb (Da Huang), the root of the Rheum plant
species (Polygonaceae), is one of the most frequently
employed herbs in treating obesity in TCM [3]. It is also the
major constituent in TCCT, XCCT, and TWCCT. Rhubarb
also appears in anti-obesity scientiﬁc research done by West-
ern scientists. In fact, use of non-prescription laxatives is a
commonly reported weight-loss behavior in Western society,
especially among those who perceive themselves as being
overweight [4, 5]. The prevalence of obesity is increasing,
along with the demand for eﬀective and safe anti-obesity
agents, including herbal medicinal products [6]. Thus,
the eﬃcacy and safety of rhubarb and rhubarb-containing
polyherbal preparations as anti-obesity and hypolipidemic
agentsshouldbesubstantiated.Therefore,weﬁrstconducted
a review of literature by retrieving all the available scientiﬁc2 Evidence-Based Complementary and Alternative Medicine
research from the following databases: Medline, Pubmed,
Chinese Electronic Periodicals Service, and Wan Fang Data.
Search terms included the following keywords in English
and Chinese: Rhei, Rhei Rhizoma, rhubarb, Rheum,D a
Huang, obesity, lipid, cholesterol, triglyceride, weight, high-
fat diet, and Triton WR-1339. All literature pertaining to
the eﬃcacy of rhubarb and rhubarb polyherbal products
in reducing body weight and lipids in human and animal
studies was retrieved and appraised. We found that rhubarb
and rhubarb-containing polyherbal preparations exhibited
potential lipid- and body weight-lowering eﬀects as reported
insomeanimalstudies,buttheeﬀectsdiﬀeredamongstudies
as shown in Table 1 [7–14].
A summary of the human clinical trials examining
the metabolic eﬀect of these herbal preparations on body
weight and lipid proﬁles is presented in Table 2 [15–22].
Overall, these studies reported the anti-obesity and hypolipi-
demic activities of three kinds of rhubarb extracts and
seven rhubarb-containing polyherbal preparations. How-
ever, fewer than half of the collected studies revealed
a signiﬁcant eﬃcacy in body-weight or lipid reduction.
Demonstrated eﬀects (or lack of eﬀects) may depend on
dosage and extract type used for a particular herb or herbs in
poly-herbalpreparations.Theresultssuggestthattheeﬃcacy
of rhubarb or rhubarb-containing polyherbal preparations
on weight loss and lipid control warrants needs further
investigation.
The development of many chronic diseases, such as coro-
nary heart disease, diabetes mellitus, fatty liver disease, are
closely related to obesity. Inﬂammation and excess oxidative
stress contribute at least partially to the pathogenesis of these
diseases[23–25].Recently,weshowedthatTCCT,inaddition
to having potent purgative activity, also has a strong anti-
inﬂammatory eﬀect. We also showed that XCCT can protect
the liver from oxidative stress [26, 27]. Hence, we postulated
thattheseherbalpurgativeremediesmayhavepotentialvalue
in the management of obesity and related conditions, such as
hyperlipidemia.Therefore,wemeasuredtheanti-obesityand
hypolipidemic activities of these three decoctions in rats fed
with a high-fat diet and in Triton WR-1339-treated mice.
2. Methods
2.1. Preparation of Aqueous Extracts. Medicinal plants and
materials used in the experiment included the root of Rheum
palmatum L. (Polygonaceae), the bark of Magnolia oﬃcinalis
Rehd. et Wils. (Magnoliaceae), the immature fruit of Citrus
aurantium L. (Rutaceae), the root of Glycyrrhiza uralensis
F. (Leguminosae), and Mirabilitum (mirabilite, crystals of
sodium sulfate, Na2SO4). The herbs were purchased from
a traditional Chinese medicinal store in Taipei, Taiwan,
and all of the materials were authenticated by Assoc. Prof.
H.C. Chang, National Laboratories of Food and Drugs,
Department of Health, Executive Yuan, Taipei, Taiwan.
Voucher specimens (No. RP-0001, MO-0001, CA-0001, GU-
0001 and M-0001) were deposited at the Herbarium of
the College of Pharmacy, Taipei Medical University. TCCT,
XCCT and TWCCT were prepared according to the Uniﬁed
Formula published by the Committee on Chinese Medicine
and Pharmacy of the Department of Health in Taiwan
(Table 3). TCCT, XCCT and TWCCT were immersed in
660, 560 and 600mL of distilled water, respectively. Thirty
grams of rhubarb was immersed in 600mL of distilled water.
The materials were boiled until half of the original water
remained, and then the extract was ﬁltered and freeze-dried
until further use.
2.2. Determination of Total Polyphenols and Total Flavonoids.
The concentration of total polyphenols in the extracts was
determined by the Folin-Ciocalteu method, according to the
previously described methods but with slight modiﬁcations
[28].Brieﬂy,adilutedsample(100mL)wasaddedtoaFolin-
Ciocalteu reagent (500mL) and 7.5% sodium carbonate
solution (400mL) and incubated at 30◦C for 5min. This
mixture was then allowed to cool down in water. The
absorbance was measured at 600nm with an ELISA reader.
The results are expressed as gallic acid equivalents.
The concentration of total ﬂavonoids in the extracts
was determined by using a vanillin reagent, according to
previously described methods but with slight modiﬁcations
[29]. Brieﬂy, a diluted sample (300mL) was added to a
vanillin-H2SO4 solution (600mL) at 20◦C for 15min. The
absorbance was measured at 530nm with an ELISA reader.
The results are expressed as catechin equivalents.
2.3. Chromatographic Analysis of Herbal Preparations. The
high-performance liquid chromatography (HPLC) system
consisted of a Shimadzu (Kyoto, Japan) LC-10ATvp liquid
chromatograph equipped with a DGU-14A degasser, an
FCV-10ALvp low-pressure gradient ﬂow control valve, an
SIL-10ADvp auto injector, an SPD-M10Avp diode array
detector, and an SCL-10Avp system controller. Peak areas
were calculated using Shimadzu Class-VP software (version
6.12 sp5).
Themobilephasewascomposedof(A)waterwith0.05%
triﬂuoroacetic acid (v/v) and (B) acetonitrile with gradient
elution in the following sequence: 0–30min: (A) 10%, (B)
90%; 30–40min: (A) 20%, (B) 80%; 40–65min: (A) 40%,
(B) 60%. Solvents were ﬁltered through a 0.45-μmF PV e r i c e l
(PVDF) membrane ﬁlter from Pall Corporation (Ann Arbor,
MI, USA). A LiChrospher 100RP-18 column (250 × 4mm
I.D.) and a Purospher STAR RP-18e guard column (4 ×
4mm I.D.) (Merck, Darmstadt, Germany) were used. The
ﬂow rate was 1.0mLmin−1 with UV absorbance detection
at 280 and 254nm. The analysis used 20μl of a sample
solution. The operation was performed at room temperature
25◦C). Authentic standards used to conﬁrm (+)-catechin,
sennoside A, sennoside B, rhein and glycyrrhizic acid in
the extracts were obtained from Sigma (St Louis, MO,
USA).Quantiﬁcationoftheaforementionedcompoundswas
expressed in micrograms per gram (μgg −1)o fe x t r a c t sa n d
was determined by a standard curve from a plot of the peak
area and matching concentrations of the standard solution.
2.4. Experimental Animals. Male Sprague-Dawley rats
(307±30g) and male ICR mice (20 ± 2g) were obtained
fromtheNationalLaboratoryAnimalBreedingandResearchEvidence-Based Complementary and Alternative Medicine 3
Table 1: Summary of studies examining the metabolic eﬀect of rhubarb or rhubarb-containing polyherbal preparations on body weight,
serum TC level, and TG level in animal models.
Ref. Animal Stress Duration Treatment
Metabolic eﬀect
Body weighta TCb TGc
[7] C57BL/6J
mice
Cholesterol
diet 4w e e k s
Rheum
rhaponticum stalk
ﬁbre (50gkg−1)
NSD (greater
weight gain in T
group)
↓∗ NR
[8]
Diabetic
BBdp rats;
SD rats
STZ (for SD
rats) 2w e e k s
Rheum
rhaponticum stalk
ﬁbre (50gkg−1)
NE (greater weight
gain in STZ group) NSD NSD
[9] Wistar rats Alloxan/
gastroparesis Once
W a t e re x t r a c t so f
Rheum palmatum
(150–300mgkg−1),
oral
NR NR
↓∗
(Postprandial)
[10] C57BL6J
mice STZ 8 weeks
70% EtOH
rhubarb extracts
(5mgkg−1)
↓∗ NR NR
[11]S D r a t s Triton
WR-1339 3d a y s DOT
(200mgkg−1) NR ↓∗ ↓∗
[12] Wistar rats High-fat diet 8 weeks NT ↓∗ NSD NSD
[13] ICR mice High-fat diet 14 weeks
IN, BO or DA
(31.5mg) mixed in
diet
↓∗ in DA and BO
group (body
growth)
↓∗ in DA and
BO group
NE (inhibition
noted but not
signiﬁcant)
[14] Beagle
dogs None 4a n d1 3
weeks ERr731 NSD NR NR
NSD, no signiﬁcant diﬀerence; ↓, reduced; NR, not reported in the study. T, treatment (experimental) group; STZ, streptozotocin; DOT, Daio-Orengedokuto,
consists of Rhei Rhizoma, Scutellariae Radix, Coptidis Rhizoma, Phellodendri Cortex and Gardeniae Fructus; IN, Yin-chen-hao-tang, consists of Rhei
Rhizoma, Artemisiae Capillaris Flos, Gardeniae Fructus; BO, Bofu-tsusho-san, consists of Rhei Rhizoma, Scutellariae Radix, Glycyrrhizae Radix, Platycodi
Radix, Atractylodis Lanceae Rhizoma, Schizonepetae Spica, Gardeniae Fructus, Paeonia Radix, Cnidii Rhizoma, Angelicae Radix, Menthae Folium,
Saposhnikoviae Radix, Ephedrae herba, Forsythiae Fructus, Zingiberis Rhizoma, Kaolinum, Gypsum Fibrosum, Natrium Sulfuricum; DA, Dai-saiko-to,
consists of Rhei Rhizoma, Bupleuri Radix, Pinelliae Tuber, Scutellariae Radix, Paeonia Radix, Zizypus Fructus, Aurantii Fructus Immaturus, Zingiberis
Rhizoma. (DOT, IN, BO, and DA are all rhubarb-containing polyherbal preparations). NT, contains 40% rhubarb root and stem; ERr 731, special dry extract
from the roots of R. rhaponticum.
aEﬀect on body weight reduction; bEﬀect on TC reduction; cEﬀect on TG reduction;
∗Statistically signiﬁcant.
Centre (Taipei, Taiwan), and maintained in plastic cages at
21±2◦C with free access to water. They were kept on a 12-h
light-dark cycle. Animal care and use protocol was reviewed
and approved by the Institutional Animal Care and Use
Committee(IACUC,ApprovalNo:LAC-95-0026).Theregu-
lations set by IACUC met international laws and regulations.
2.5.TritonWR1339-InducedHyperlipidemia. MaleICRmice
were fed a commercial diet and water ad libitum, and were
kept in cages for observation for 7 days prior to the exper-
iment. Animals were divided into seven groups of ﬁve mice
each: a blank group, a control group and ﬁve experimental
groups. The experimental groups received additional daily
oral feeding of aqueous extracts of TCCT, XCCT, TWCCT
or R. palmatum (200mgkg−1), or fenoﬁbrate (65mgkg−1,
as positive control) once a day for 3 days. An intraperitoneal
injection of Triton WR-1339 (100 or 400mgkg−1;T y l o x a p o l ,
Sigma,USA)wasadministeredtoalltheanimalsexceptthose
in the blank group, an hour after the last dose of extract
or drug was given. Eighteen hours after the injection and
under light anesthesia, blood was drawn from the orbital
vein of all the animals to measure serum total cholesterol
(TC) and triglyceride (TG) with a FUGI DRI-CHEM 3500i
analyser (Fuji Film, Japan), according to the manufacturer’s
instruction. The experimental procedure for the Triton WR
1339 experiment is shown in Figure 1(a).
2.6. Diet-Induced Hyperlipidemia and Obesity. Hyperlipi-
demia and obesity developed in animals fed on a high-fat
diet. In this experiment, the male Sprague-Dawley rats were
divided into six groups of six rats each; a blank group was
fed a regular diet, a control group was fed a high-fat diet,
and four experimental groups were fed the high-fat diet
supplemented with daily administration of aqueous extracts
of TCCT, XCCT, TWCCT or R. palmatum (200mgkg−1)
once by intragastric gavage. The ingredients of the high-
fat and regular diets contained equal amounts of casein
(14%), dextrin (15%), sucrose (10%), soybean oil (4%),
cellulose (5%), mixed minerals (4%) and mixed vitamins
(1%). The high-fat diet contained additional 4% lard, 0.3%
cholesterol, 0.03% choline and 0.03% cholic acid. Corn
starch comprised 46% of the standard rat chow diet and 42%
of the high-fat diet. All the diets were prepared weekly and
stored at 4◦C. During the experimental period (28 days),
body weight and food intake were recorded daily. Under
light anesthesia, blood was drawn via the tail vein on days4 Evidence-Based Complementary and Alternative Medicine
Table 2: Summary of human clinical trials examining the metabolic eﬀects of rhubarb or rhubarb-containing polyherbal preparations on
body weight, serum total cholesterol (TC) and triglyceride (TG).
Ref. Study type Subjects Treatmentc Duration
Metabolic eﬀect
Body weighta TCb TGc Adverse eﬀects
[15]Case series
10 men with
hyper-
cholesterolemia
Fibre of Rheum
rhaponticum
(27g)
4 weeks NSD ↓∗ (8%) ↓ none
[16]R, case-
control
95 pregnancy
induced
hypertensive
women
Diet control and
Western
medication with
or without
prepared
rhubarb (3–9g)
6–8 weeks NR T: NSD T:↓∗ NR
[17]Case series 232 NAFLD
patients Danning Pian 3 months NSD NSD ↓∗
15.1% including
diarrhoea [32], itchy
skin [1], nausea [3],
increased ALT [2]
[18]R,db,pc
81 obese female
with impaired
glucose
tolerance
Diet and
exercise with
either Bofu-
Tsusho-San
(BO) or placebo
24 weeks P: ↓∗ (7.6%);
T: ↓∗ (11.8%) P: ↓∗;T :↓∗ P: ↓∗;T :↓∗
3i nB Og r o u p
dropped out due to
noncompliance
because of loose stool
[19]R,db,pc
110
perimenopause
women
ERr731 or
placebo 12 weeks P:NSD
T:NSD NR NR No
[20]R, case-
control
24 healthy
women
Diet control
with NT
(250–500mg)
or placebo
12 weeks P:↓, T:NSD NR NR Dose-dependent soft
stool in T group
[21]R,
P-control
105 healthy
volunteers
Low or high
dose of mixture
of NT with
gallic acid or
placebo
24 weeks
P: ↓,T ( l o w
dose): ↓;T
(high dose): ↑
NSD NSD
40% cases dropped
out due to
ineﬀectiveness
[22]R, db,
control
135 NAFLD
patients T: Danning Pian 24 weeks C:NE; T:↓∗ C:↓;T :↓ C:↓∗;
T: ↓∗
T: most showed
diarrhoea, skin rash
[1], nausea [3]
NSD, no signiﬁcant diﬀerence; ↓, reduced; NR, not reported in the study; ↑, increased. R, randomized; db, double-blind; pc, placebo-controlled; P, placebo
group;T,treatment(experimental)group;C,controlgroup.NAFLD,non-alcoholicfattyliverdisease;ERr731,extractfromtherootsofRheumrhaponticum;
NT, contains 40% rhubarb root and stem; Danning Pian: each tablet contain 4.5g Radix et Rhizoma Rhei. BO, Bofu-tsusho-san, consists of Rhei Rhizoma,
Scutellariae Radix, Glycyrrhizae Radix, Platycodi Radix, Atractylodis Lanceae Rhizoma, Schizonepetae Spica, Gardeniae Fructus, Paeonia Radix, Cnidii
Rhizoma, Angelicae Radix, Menthae Folium, Saposhnikoviae Radix, Ephedrae herba, Forsythiae Fructus, Zingiberis Rhizoma, Kaolinum, Gypsum Fibrosum,
Natrium Sulfuricum.
aEﬀect on body weight reduction; bEﬀect on TC reduction; cEﬀect on TG reduction;
∗Statistically signiﬁcant.
14 and 28 to monitor changes in serum lipids as well as
the kidney and liver functions. Biochemical analysis was
performed with a FUGI DRI-CHEM 3500i analyser (Fuji
Film, Japan) according to the manufacturer’s instruction.
The experimental procedure for the high-fat diet experiment
is shown in Figure 1(b).
2.7. Statistical Analysis. Data were ﬁrst statistically assessed
by the Kruskal-Wallis one-way analysis of variance by rank.
Diﬀerences between the drug-treated groups and the control
group were then evaluated by the Mann-Whitney test. The
diﬀerences were considered to be statistically signiﬁcant at
the P<. 05. All data were expressed as the mean ± standard
deviation (SD).
3. Results
3.1. Total Polyphenols and Flavonoids in the Extracts. Con-
centrations of total polyphenols in the extracts of TCCT,
XCCT, TWCCT, and R. palmatum used in the experiment
were in the order of R. palmatum > XCCT > TWCCT >
TCCT. Concentrations of total ﬂavonoids in these extracts
also exhibited similar order as described in Table 3.
3.2. Concentrations of Major Compounds in the Extracts.
The major compounds in TCCT, XCCT, and TWCCT were
analyzed and quantiﬁed with HPLC. Concentrations of (+)-
catechin, sennoside A and sennoside B in each decoction
were in the order of R. palmatum > XCCT > TCCT >Evidence-Based Complementary and Alternative Medicine 5
Table 3: Constituents and chemical proﬁles of TCCT, XCCT, and TWCCT.
Formula
name Constituent Weight
(g)
Yield
(%)
Catechin
(μgg −1)a
Sennoside B
(μgg −1)a
Sennoside A
(μgg −1)a
Rhein
(μgg −1)a
Glycyrrhizic
acid
(μgg −1)a
Total
polyphenols
(μgmg −1)b
Total
ﬂavonoids
(μgmg −1)c
R. palmatum 8 27.3 3025.8 ± 90.5 3214.2 ± 106.1 1815.4 ± 60.8 251.2 ±
19.0 — 110.3 ± 1.1 24.4 ± 0.7
TCCT M. oﬃcinalis 16
C. aurantium 3
Mirabilitum 6
R. palmatum 14 19.3 5828.1 ± 21.0 3945.6 ± 10.9 2458.0 ± 18.0 657.6 ±
17.5 — 11.5 ± 10.9 123.8 ±
0.4
XCCT M. oﬃcinalis 7
C. aurantium 7
R. palmatum 12 31.9 2904.6 ± 45.1 1998.0 ± 125.1 1565.8 ±
119.6
382.7 ±
9.70 336.8 ± 51.0 117.5 ± 12.5 40.1 ± 1.7
TWCCT Mirabilitum 12
G. uralensis 6
R. palmatum 30 12.21 6729.1 ±
163.1 4024.6 ± 121.5 3170.0 ± 96.2 681.3 ±
20.7 — 255.5 ± 14.0 165.9 ±
3.7
aThe amount is expressed as μgg −1 of extract; bThe content is expressed as μg of gallic acid equivalent per mg of extract; cThe content is expressed as μgo f
catechin equivalent per mg of extract.
(day)
123
Blood drawn
for analysisa
18hr
Exp. drug (p.o.) E x p .d r u g( p.o.)E x p . d r u g ( p.o.)
Triton WR 1339 (i.p.)
(a)
(day)
123
Blood drawn
for analysisa
18hr
Exp. drug (p.o.) E x p .d r u g( p.o.)E x p . d r u g ( p.o.)
Triton WR 1339 (i.p.)
(b)
Figure 1: Experimental ﬂow chart for the Triton WR 1339
experiment (a) and high-fat diet experiment (b). aBlood drawn via
orbital veins for TC and TG analysis. bBlood drawn via tail veins for
ﬁrst TC, TG analysis. cBlood drawn via tail veins for second TC, TG
and Cr, GPT analysis.
TWCCT. The concentration of rhein was in the order
of R. palmatum > XCCT > TWCCT > TCCT (Table 3).
Since TWCCT was the only extract containing G. uralensis,
glycyrrhizic acid was present only in TWCCT.
3.3. TWCCT Lowered the Serum Triglyceride Level in Mice
Treated with Triton WR 1339. Eighteen hours after the
intraperitonealinjectionof100mgkg−1 TritonWR-1339,the
c h a n g ei ns e r u mT Gl e v e ld i ﬀered signiﬁcantly (P<. 05).
As shown in Figure 2, pair-wise comparisons between the
diﬀerent extract-treated and vehicle-treated animals revealed
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Figure 2: Eﬀects of TCCT, XCCT and TWCCT on serum
triglycerides in Triton WR 1339 (100mgkg−1)-treated mice. Bars
represent the mean ± SD.
∗P <. 05.
a statistically signiﬁcant elevated serum TG level in the
control group as compared to the blank group (P<. 05).
TWCCT pretreatment signiﬁcantly reduced the serum TG
level as compared to the control group (P<. 05). Finoﬁbrate
pretreatment also showed a signiﬁcant reduction of serum
TG (P<. 05).
Eighteen hours after the intraperitoneal injection of
400mgkg−1 Triton WR-1339, the serum TC level in the
control group showed a signiﬁcant elevation as compared
to the blank group (P<. 05). However, none of the
pretreatments reduced the TC level signiﬁcantly.6 Evidence-Based Complementary and Alternative Medicine
Table 4: Changes in body weight, food intake, and feed eﬃciency in rats fed diﬀerent diets.
Blank Control TCCT XCCT TWCCT Rhubarb
Daily weight change (g) 2.5 ± 1.0 4.2 ± 0.6∗ 3.5 ± 0.7 4.3 ± 0.5 4.3 ± 0.4 3.9 ± 1.1
Daily food intake (g) 21.0 ± 1.4 22.0 ± 1.3∗ 20.8 ± 1.3 23.0 ± 1.3 22.7 ± 0.5 20.3 ± 1.8∗
Feed eﬃciency (%) 12.3 ± 4.5 18.6 ± 2.9 17.0 ± 3.6 18.6 ± 2.9 19.1 ± 2.0 19.2 ± 5.2
∗P <. 05.
Blank Control TCCT XCCT TWCCT Rhubarb
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Figure 3: Eﬀects of daily feeding of TCCT, XCCT and TWCCT on
serum cholesterol (a) and triglycerides (b) in rats fed the high-fat
diet.Barsrepresentthemean ±SD.
∗P <. 05.Percentofchangecal-
culatedas=((dataofweek4–dataofweek2)/dataofweek2) ×100.
3.4. XCCT and TWCCT Lowered the Lipid Proﬁle in Rats on a
High-Fat Diet. The eﬀect of high-fat feeding on lipid proﬁle
over a 28-day period, with or without co-feeding the exper-
imental herbal extracts, was examined by the percentage of
change in serum TC and TG levels, obtained from blood
drawn on the 14th and 28th days of the experiment. The
changes in both serum TC and TG levels were signiﬁcant
(P<. 05). As shown in Figure 3(a), pair-wise comparisons
revealed statistically signiﬁcant elevated serum TC level in
the control group as compared to the blank group (P<. 05).
XCCT or TWCCT co-treatment signiﬁcantly reduced
the serum TC level as compared with the control group
(P<. 05 in both the cases). The high-fat diet also induced
signiﬁcant elevation of TG level (P<. 05; Figure 3(b)). Daily
TWCCT co-treatment signiﬁcantly attenuated the elevated
TG concentration associated with high-fat diet consumption
(P<. 05; Figure 3(b)).
3.5. TCCT, XCCT and TWCCT Did Not Aﬀect Body Weight,
Food Intake and Feed Eﬃciency in Rats on a High-Fat Diet.
Theeﬀectsofhigh-fatfeedingwithorwithoutco-feedingthe
experimental herbal extracts on body weight change, food
intake and feed eﬃciency (FE%) were also examined. As
shown in Table 4, the variations in body weight and food
intake were signiﬁcant (P<. 05 in both the cases). Pair-wise
comparisons revealed statistically signiﬁcant elevated body
weight and food intake in the control group as compared
with the blank group (P<. 05 in both the cases), and sta-
tistically signiﬁcant reduced food intake in the R. palmatum
co-treatedgroupascomparedtothecontrolgroup(P<. 05).
3.6. TCCT, XCCT, TWCCT and Did Not Aﬀect Renal and
Hepatic Functions in Rats on a High-Fat Diet. In order to
evaluate possible renal and hepatic toxicity resulting from
chronically feeding the animals on these herbal preparations,
we examined the serum creatinine and GPT concentra-
tions, obtained from blood drawn on the 28th day of
the experiment. In all the experimental groups, there was
no signiﬁcant change in either serum creatinine or GPT
level (data not shown). In addition, none of the animals
experienced diarrhea during the experimental period.
4. Discussion
Modernization of TCM theory by using modern science
technology and modern medicine theory is essential for
the integration of old wisdom with modern medical lan-
guage. This strategy and policy to integrate ancient medical
knowledge with modern technology and medicine has been
advocated in both Oriental and Western societies [30, 31].
According to Shan Han Lun, when the evil heat binds
internally, many symptoms and signs may be produced, such
as abdominal fullness and pain, constipation, thirst, even
fever and delirium in severe cases [2, 32]. The traditional
principle of treatment is to purge the evil internal heat
with purgatives such as the three prescriptions used in
the present study, based on the severity of symptoms
[33]. In the present study, we measured the anti-obesity
and hypolipidemic activities of these three decoctions with
two diﬀerent prevailing and relevant and in vivo models.
TWCCT treatment not only decreased the Triton-induced
hypertriglycemia, but also signiﬁcantly reduced the elevatedEvidence-Based Complementary and Alternative Medicine 7
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Hyperlipidermia
Figure 4: Proposed action of hypolipidermic purgatives on lipid metabolism.
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Figure 5: Integration of three ancient purgative formulas with modern language and science.
TG concentration induced by high-fat diet consumption.
XCCT was the other potential lipid-modifying purgative
preparation in this study. A high serum cholesterol level
induced by high-fat diet was inhibited signiﬁcantly by
XCCT co-treatment. The results suggest the potential ben-
eﬁcial eﬀects of TWCCT and XCCT in managing hyper-
triglycemia. A hypothetical diagram explaining the mecha-
nism of TWCCT and XCCT-related hypolipidemic activity
is shown in Figure 4. Previously, we used LPS-stimulated
RAW264.7 murine macrophages and a carrageenan-induced
paw edema in mice to show that TCCT has a potent anti-
inﬂammatory eﬀect in addition to its traditionally known
strong purgative activity. The result suggests that TCCT
may be indicated to alleviate inﬂammatory conditions in
patients with concomitant constipation [26]. Next, we used
well established models to assay the antioxidant activity
in 3 CCTDs in vivo or in vitro, namely, 1,1-diphenyl-2-
picrylhydrazyl(DPPH)radicalscavengingtest;measurement
of malonedialdehyde (MDA) level in Butylhydroperoxide
(TBH); and CCl4-induced lipid peroxidation. The results of
that study suggest that XCCT has a signiﬁcant antioxidant
activity and hepatic protection potential [27]. We developed
a ﬂowchart diagram to explicate our work on the translation
of these ancient formulas into modern language, shown in
Figure 5.
To the best of our knowledge, this is the ﬁrst report
of comparing the lipid-modifying eﬀects of these three
purgative formulations with fenoﬁbrate, a third-generation
ﬁbric acid derivative, synthesized in 1975 [34]. Triton-
induced hypertriglycemia was similarly lowered by pretreat-
ment with the TWCCT extracts (about 45%) and fenoﬁbrate
(about 35%), shown in Figure 2. The result suggests that8 Evidence-Based Complementary and Alternative Medicine
the mechanism of action of TWCCT on lipid metabolism
may be similar to that of fenoﬁbrate. Fibrates usually reduce
plasma levels of triglycerides by 30–50%, attributable to the
activation of the nuclear transcription factor peroxisome
proliferator-activated receptor alpha (PPARα). The activa-
tion of PPARα then alters the transcription rate of target
genes associated with lipid metabolism and inﬂammatory
response, such as lipoprotein lipase, β-oxidation pathway,
and COX-2 [35]. R. palmatum is the only common con-
stituent in XCCT and TWCCT, and also the principle herb
in these two preparations by TCM. Lipids are metabolized
in several tissues, including adipose tissue, liver, intestine
and muscles. Rhubarb extracts have been found to enhance
gastrointestinal transit and contractility [9, 36]. Rhubarb
extracts also enhance bile excretion and inhibit the activity
of pancreatic lipase, HMG-CoA, and squalene epoxidase
[11, 37]. Sennoside B and rhein reduce the diﬀerentiation of
adipocytes and the accumulation of triglyceride within cells
[10]. Dietary products rich in ﬂavonoids and polyphenols
have been reported to correlate with lower plasma TC con-
centrations and plasma LDL cholesterol concentrations in
humans [38–41]. In the chromatographic analysis, we iden-
tiﬁed the existence of signiﬁcant amounts of polyphenols,
ﬂavonoids, and compounds such as catechin, sennosides and
rhein in the extracts of our experiments. Major compounds
found in citrus, magnolia, and licorices also have shown
serum lipid-lowering eﬀects [42–44]. Together, these may
contributetothehypolipidemiceﬀectofTWCCTandXCCT.
However at present, the chemical constituents identiﬁed in
this experiment could be used as reference standards to
ensure the quality of herbal products and the validity of
the comparison between studies using the same product.
However, the precise mechanism by which TWCCT and
XCCT inﬂuence the serum TG and TC responses remains to
be determined.
In our study, the co-treatment of R. palmatum extract
signiﬁcantly reduced the food intake of the high-fat diet
animals, but it did not reduce their body weight signiﬁcantly.
We also demonstrated that at the particular dosage used
in the experiment, rhubarb did not reduce the serum
lipid level of animals fed with a high-fat diet. In high-fat
feeding experiment, higher FE was an indicator of the ease
with which animals gain weight from what they eat [45].
All experimental and control groups showed higher feed
eﬃciencies than the blank group. This result suggests that
these purgatives have no anti-obesity eﬀect. Previous studies
alsodemonstrated thatlaxatives areeither ineﬀectiveweight-
reducing agents, or they induce adverse events [5, 46–48].
Therefore, clinicians should be discouraged in using these
purgative preparations for the purpose of weight reduction.
5. Conclusions and Directionsfor
FutureResearch
In conclusion, the results suggest that TWCCT and XCCT
might exert beneﬁcial eﬀects in the management of hyper-
lipidemia. Further mechanistic and clinical studies are
needed to conﬁrm the clinical usefulness of TWCCT and
XCCT.
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